Optimal Duration of Hormone Therapy

Posted by oldgreenpaint @oldgreenpaint, Mar 11 7:27am

Not a question, but a discussion item for the Group. This video from PCRI just dropped yesterday and reviews a JAMA study that focuses on best duration of hormone therapy. About 20 minutes long. One really interesting finding is that the longer the duration the higher the likelihood of dying from something other than PC. (As compared to control groups not on ADT ). Probably cardio vascular, osteoporosis caused bone fractures, diabetes…….known side effects. My analysis on the last statement. Anyway, my take on it is that duration of ADT is becoming a more discussed issue and the unintended impacts on a man’s body are starting to be paid more attention to.

Interested in more discussions like this? Go to the Prostate Cancer Support Group.

Profile picture for kujhawk1978 @kujhawk1978

A good question...

Studies and statistics say...!?

As my radiologist said when she sits on the hospital tumor boards, the oncologists are all over the map when it comes to which agents, how long and their rationale.

Generally, I see 6-36 months in guidelines and clinical trails if definitive treatment is a choice.

With indefinite, well, the lengthy decision is taken out of the equation.

So, if deciding on systemic therapy, with what, how long. We know the differences generally between Lupron, Orgovyx, Casodex... We also know the differences between say Nubeqa and say Xtandi. We can list the know side effects, questions unknown is which ones will we experience and to what degree?

What are the pieces of the systemic therapy therapy decision making...?

Well, there is the science, GS, GG, Biopsy report, Pathology report from surgery, lab results, PSA, PSADT and PSAV, testing such as Decipher, Genomic, Dexa Scans...low, intermediate, high risk...heck, GS 8 vs 9-10, is there really a difference in making our systemic therapy decision...the medical community says yes and points to data from clinical trails - PFS, RPFS, OS...

Then there is science associated with co-morbidities - cardiovascular, diabetes, kidney function, weight, pulmonary...

What about drug interactions,,,? My oncologist was hesitant to prescribe Xtandi until was my cardiologist was on board due to interactions with Eliquis.

Lest we forget insurance, national health system rules...

Don't forget our medical teams, some who may not be as current as we are!

Trying to apply the science, the NCCN and AUA guidelines plus clinical trails to our specific clinical data. Keeping in mind that because they are the science, the rigor required, they may be dates, they ARE population based...

This is a hetero, not homogeneous disease, my PCa is not yours, the SEs I experience and the severity may not be yours, my T recovery when de-intensifying may not be yours, my insurance is not yours...

Maybe most important, the outcomes we want, quality of life while keeping in mind longevity.

Will the side effects over time degrade the quality and quantity of my life? My radiologist once said "Kevin, if you die of a heart attack, we have succeeded in you not dying of PCa...!"

All that's before we get to the discussion of duration of systemic therapy!

About that duration...

Both times I did systemic therapy, the duration was open to discussion between my medical team and I. In the case of my first time, 24 months Lupron in conjunction with six cycles Taxotere and 25 IMRT to the Whole Pelvic Lymph nodes was the agreed upon duration between Dr. Kwon and I. There were studies which pointed to 18 or 36 months. There were also studies which pointed to 18 months being as effective as 24 and 36. So, at 18 months, an early adopter of de-intensification if PSA drops to undetectable in the first 3-6 months and stays there, ok to come off treatment and actively monitor, we did.

The 2nd time is familiar to many of you. I wanted to do SBRT and six months systemic therapy, aka the SPORT trial. My radiologist agreed with that. My oncologist on the other hand advocated for the SBRT but 24 months systemic therapy, Orgovyx + Xtandi, yikes! We settled as you know on SBRT +_12 months Orgvyx, hold the Xtandi unless PSA did not drop to undetectable in the first three months and revisit a decision at 12 months to de-intensify or continue systemic therapy to 24 months. My radiologist supported coming off, my oncologist...we came off, my radiologist told my oncologist that I would actively monitor while off and would go back on treatment when the clinical data said it was time to do so. Here we are, 24 months later, the clinical data has not said so!

As to the question of "time to resistance..." Well, ditto.

My path has been to make hybrid decision, the guidelines are a starting point, we then look at clinical trails, review ALL the clinical trails and based on the question, is this likely to work for the next 3-5 years, decide. I am not sure of the value of a time horizon longer than that. As to the OS differences, well, just getting up in the morning means you are exposing yourself to situations that may end your time on this earth, that idiot who ran the stop sign,,,

I remember sitting with my mom when her oncologist told her at best chemotherapy could extend life six months but she may not like the quality of that life. She looked at me, me, my sisters and said, no thanx, tree weeks later, gone, albeit at home, hospice with all of us around.

Kevin

Jump to this post

@kujhawk1978 same scene with my Mom.

REPLY

That was kinda my understanding from the beginning too with my husband that he'd get no adt break so my other worry is that I'll find him dead from a heart attack or he gets hurt at the gym...
It sucks!

REPLY
Please sign in or register to post a reply.